Articles

Uruguay, one of the most stable economies in Latin America, is increasingly looking to China to boost trade and growth.

China’s auto market offers a great case study for much of what is happening with China’s economy. Like much of China’s broader economy, the market is slowing.

Cryptocurrencies continue to fuel debate among regulators and users.

Imagine this: if your beloved one was diagnosed of a fatal cancer, dealing with heartbreaks aside, you had to start borrowing money for the treatment.

The backlash against global trade and the resurgence of protectionism is increasingly evident, mostly out of the U.S.

South Korea’s latest moves to make drugs more affordable are slowing down the growth of the pharma market in the country and maybe hurting sales of new and innovative drugs.

There has been so much discussion of the United States pivot to Asia that few people have stopped to consider the implications or the success of China’s own pivot to America.

All the talk that has erupted in the past couple of weeks about possible trade wars between the United States and China has been interesting in the way that a soap opera is interesting: lots of drama with little link to reality.

Fast growing Asian countries have “eliminated” poverty at an astonishing speed, bringing people out of extreme poverty into mere gut-reaching poverty.

There are few issues with just two sides or a clear right and wrong.

This is a recurrent theme for us and one that Sergio Held makes quite clear in a recent story for Ozy that considers the difficulty that Colombia is facing in cutting down on drug production.

It has been a long time coming, but the first dengue vaccine should hit the market next year in Mexico and, with any luck, in about 20 markets over the next couple of years.

This year’s BOAO Forum for Asia (BFA) has a theme of Asia’s New Future: New Dynamics, New Vision.

China is not a powerhouse of innovation, yet, but it is certainly trying to pay its way into that particular status.

It is no surprise that the life science sector including pharmaceutical, medical devices etc. is one of the hottest investment destinations.

When Indonesia’s Investment Coordinating Board (BKPM) rejected some 6,541 foreign investment permits last month, it underscored a problem Indonesia has been facing for a couple of years. Investors are looking at the country.

Environment, productivity and work hours are all big issues

Cheap oil has helped Indonesia eliminate punishing subsidies and while the move is likely to bump inflation up, it will also free up a about US$21 billion that the government can now spend on infrastructure or social programs.

While many see Hong Kong as ideally positioned to become a global hub for digital currencies and internet finance, the road forward seems far from clear.

After years of waiting, Chinese biosimilar makers will soon have a set of guidelines to follow.

The government of Venezuela, which owes medical device companies around the world more than US$245 million, is now calling for the arrest of domestic device distributors.

Eight days into the protests that have shut down entire neighbourhoods of the city, things are looking… ah… complicated.

Vaccines are great. They are arguably one of the most important public health tools of the last century.

Malaysia’s central bank welcomed Ramadan fasts and celebrations through July and August by raising the country’s interest rate for the first time in three years.

The World Cup is finished, much to the chagrin of our favorite Argentine team that came so close to taking a third cup only to see their chances vanish on a single but great German goal in overtime.

Japan’s healthcare industry has been marked by a fascinating dichotomy for the last couple of decades. A dichotomy that hurt patients most of all.

The chaotic Latin American market is key to publications in a wide range of areas and is one that those with a focus on Asia often overlook.

A new report suggests Chinese FDI in U.S. high tech may not be as scary as popular opinion there would have us believe.

Japan’s efforts to recreate its healthcare funding system provides at least one reason behind the ongoing bull market in healthcare and biotech.

When major earthquakes all but destroyed Sumatra, in Indonesia, in 2004, a well-established tradition of volunteer labor made it possible for the region to recover.